Importance: This study is the first to compare the extended range of vision (ERV) intraocular lens (IOL) targeted at micro-monovision to a monofocal targeted at binocular emmetropia.
Background: Compares visual acuity, range of vision and spectacle independence in monofocal and ERV IOLs.
Design: Assessor-blinded retrospective cohort study.
Participants: Eighty-eight participants (176 eyes) with bilateral IOL implants at 5+ month postoperative review. Results: There was no significant difference between ERV and monofocal groups in uncorrected binocular visual acuity at distance (P = 0.595). Binocular uncorrected visual acuity at intermediate (0.63 m: monofocal 0.24, ERV 0.09, P < 0.001) and near (0.40 m: monofocal 0.42, ERV 0.18, P < 0.001) were significantly better in the ERV group. Binocular uncorrected near vision: all the ERV group read N8 or better, compared to 36% in the monofocal group (P < 0.001); 93% of the ERV group reported spectacle independence at near compared to 33% in the monofocal group (P < 0.001).
Conclusions and Relevance:
The ERV IOL, targeted to achieve micro-monovision, demonstrated superior range of visual acuity and spectacle independence compared to the monofocal targeted to achieve emmetropia.
INTRODUCTION
Recent technological advances in intraocular lenses (IOLs) have focused on correcting presbyopia and achieving full spectacle independence. The first and most common presbyopia-correcting IOL was the multifocal. This design corrected for presbyopia but had inherent disadvantages. Splitting the light reduced contrast sensitivity, sometimes by up to 50%. 1, 2 This imposed a potential safety risk by reducing visual function in low light settings. 3 Some patients also experienced photic phenomena (haloes, glare, starbursts etc.) 1 which resulted in decreased patient satisfaction and surgeon confidence in this lens type. 4 Recently, a new type of presbyopia-correcting IOL has been developed, integrating pre-existing diffractive and refractive technologies to split light in a unique way. Diffractive echelettes are embedded on its optical surface, which theoretically extends the depth of focus and creates a greater range of useful uncorrected vision. 5 Also, negative dispersion refractive technology is used to correct for chromatic and spherical aberration and increase retinal image quality, as collapsing the aberration curve increases the available light. 5 These refractive and diffractive technologies were used in the Tecnis Symfony Extended range of vision (ERV) IOL (Johnson and Johnson Vision Santa Ana, CA, USA); the first ERV IOL.
To date, there have only been two clinical studies comparing visual acuity and spectacle independence between the ERV and monofocal IOLs. The first was a manufacturer published open label, multi-centre pilot study where 31 participants received bilateral ERV IOLs and 10 participants received bilateral monofocal IOLs. 6 The second was Pedrotti et al.'s prospective cohort study where 25 participants received bilateral ERV IOLs, and 15 participants received bilateral monofocal IOLs. 7 Both studies assessed visual acuity outcomes 3 months postoperatively. The ERV IOL in both studies provided clinically superior uncorrected visual acuity in the intermediate and near range compared to the monofocal. Both studies identified no statistically significant differences in binocular visual acuity between groups at distance but statistically significant greater spectacle independence in the ERV IOL group and comparable photic phenomena and contrast sensitivity between the two IOL types. 6, 7 The CONCERTO study was a prospective case series of 411 patients who had bilateral implantation of the ERV IOL. 8 The comparison groups were 299 patients for whom emmetropia was targeted, and 112 patients for whom micro-monovision was targeted. Micro-monovision involves prescribing one ERV IOL to achieve emmetropia, with the other ERV IOL prescribed to achieve a slightly more myopic focus (−0.5D). The aim is to increase spectacle independence for near vision, while maintaining adequate uncorrected distance vision. The authors identified significantly better uncorrected intermediate and near visual acuity in the micro-monovision group than the emmetropia group. While the CON-CERTO study demonstrated the capacity of micromonovision for increasing visual range, 8 to the best of our knowledge, no existing study has compared visual outcomes for ERV IOLs prescribed to achieve micro-monovision with visual outcomes achieved with monofocal IOLs. The aim of this study was to compare the visual acuity, range of vision and spectacle independence provided by monofocal IOLs at emmetropia and ERV IOLs prescribed to achieve micro-monovision.
METHODS

Study design
A retrospective cohort study was used to compare visual acuity, range of vision and spectacle independence in participants who had received either monofocal or ERV IOLs.
Participants were recruited and visually tested from June to August 2016 at an Australian ophthalmology clinic. Consecutive patients attending the clinic for routine postoperative follow-up, at least 5 months after implantation of the patient's second IOL, were invited to participate. Clinic reception staff obscured IOL type in the clinical records, and provided a code (1 or 2) to the investigators for lens type, thereby blinding the investigator to the IOL type that each participant received. Clinic staff assessed patients' study eligibility according to the following exclusion criteria: comorbid ocular pathology such as uncontrolled glaucoma, corneal and retinal diseases. To reduce the influence of performance and detection bias, lens type was only revealed to the investigators upon completion of data collection.
Intraocular lenses
Participants in the ERV IOL group had the Tecnis Symfony IOL implanted and the monofocal IOL group had either the aspheric ZA9002 Tecnis with an optical zone diameter of 6 mm. The Symfony and ZCT IOLs are made of an ultravioletblocking hydrophobic acrylic with a refractive index of 1.47. 9 In comparison the ZA9002 is made of ultraviolet-blocking SLM-2 silicone with a refractive index of 1.46. 10 In the ERV group, the IOL power selection aspired to achieve micro-monovision, whilst in the monofocal group, the IOL power selection aspired to achieve emmetropia. Eye dominance was routinely assessed in participants in the ERV group as it has been suggested that eye dominance is an important factor for subsequent patient satisfaction when using micro-monovision. 11 This was done by asking the patient to look through a small aperture to focus on a distant target. They were then asked to close each individual eye whilst not moving their head and report if the target disappeared. The eye that maintained view on the target when the other eye was closed was considered the dominant eye. The IOL power selections aspired to achieve emmetropia in ERV group participants' dominant eyes and −0.5D in their non-dominant eyes.
For all participants astigmatism correction aspired to achieve the nearest value to 0.0D available with axis flip allowed.
Data collection
Data were collected by a single investigator. Preoperative visual acuity data were extracted from each participant's medical file. Spherical equivalent refractive targets were selected for participants' left and right eyes using biometric information obtained using the IOL Master (version 5.4; Carl Zeiss Meditech AG, Germany) and recorded. Postoperative visual acuity was tested and self-reported spectacle usage was recorded at the 5+ month routine followup appointment.
Visual acuity was assessed using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart, read at distance Participants were tested monocularly and binocularly with both uncorrected and best distance refractive correction in place. In addition, near visual acuity was further tested binocularly without best distance correction, using a reading chart which was calibrated according to the British N notation, enabling extra elements of near visual capacity such as fluent optotype recognition and reading speed to be ascertained.
Participants were subjectively tested for reading speed. If the individual paused for more than 3 s on a single occasion while reading or paused for 1 s on three separate occasions they were asked to move up a line until they read fluently. If the participant was unable to read fluently at any level, it was recorded as a failed test. The investigator only recorded the N level at which the participant read proficiently.
Participants' spectacle usage was assessed by asking 'Do you use spectacles at all for distance?' and 'Do you use spectacles at all for near activities (e.g. knitting or reading)?' If the participant answered yes to either question, the participant was asked 'If you were to take an estimate, what percentage of time do you use glasses for distance vision/near vision?', respectively.
Statistical analysis
Data were entered and analysed using Stata/SE 14.0 (StataCorp LP, College Station, TX, USA).
Two sample t-tests were used to investigate differences in binocular reading chart scores, age, IOL power, spherical equivalent refractive target and outcome and cylinder. A two-sample Wilcoxon rank-sum test was used to compare months since most recent surgery and % time spectacles were used at distance and near. The chi-squared test was used to test for differences between monofocal and ERV groups in sex, toricity and spectacle independence. A paired comparison between preoperative and postoperative monocular best-corrected visual acuity was made using the Wilcoxon signed rank test.
For analyses of monocular visual acuity, separate multiple generalized estimating equation (GEE) models with an identity link function and exchangeable correlation structure were used. GEE is a type of regression model which enables adjustment for any correlation between each participant's left and right eye which is important when modelling monocular vision outcomes. The GEE models tested associations between IOL type and monocular visual acuity, after adjusting for age, posterior capsular opacification treatment and for setting an aspirational micro-monovision target of −0.5D in the nondominant eye in the ERV group. When testing associations between IOL type and monocular unaided visual acuity, adjustments were additionally made for any residual astigmatism. Multiple linear regression models were used to test associations between IOL type and binocular visual acuity, adjusting for age and posterior capsular opacification. When testing associations between IOL type and binocular unaided visual acuity, adjustments were additionally made for any residual astigmatism in either eye of each participant.
This study was approved by Monash University Human Research Ethics Committee: CF16/867-2016000436.
RESULTS
There were 88 participants (176 eyes) in this study: 45 (90 eyes) (51.14%) and 43 participants (86 eyes) (48.86%) in the monofocal and ERV groups, respectively. There were no statistically significant differences in sex or time since most recent cataract surgery between monofocal and ERV IOL groups, however the ERV IOL recipients were significantly younger than the monofocal IOL recipients (Table 1) .
There were no significant differences in preoperative visual acuity between monofocal and ERV IOL groups. There were, however, statistically significant differences in IOL power and spherical equivalent refractive targets between the groups, with resultant statistically significant differences in spherical equivalent outcomes obtained in the ERV group compared to the monofocal group (Table 2) . This is consistent with aspirational targets of micromonovision in the ERV group and emmetropia in the monofocal group.
Statistically significantly better monocular intermediate and near vision were obtained in the ERV group irrespective of whether visual acuity was assessed uncorrected or with best distance refractive correction (Table 3 ). These differences in visual acuity were greater than one line on the ETDRS chart (0.1 LogMAR) for near and intermediate 0.63 m distances, suggesting that the ERV IOL is generally associated with clinically significant improvements in visual acuity at distances commonly used for reading and looking at electronic screens. While the differences in visual acuity between monofocal and ERV IOL group were also statistically significant at 1.00 m distance, the differences (0.08 LogMAR units uncorrected and 0.06 LogMAR units corrected, respectively) were less than one line on the ETDRS chart and therefore may not be clinically important. The greatest differences in visual acuity were at near, with the ERV group reading at least two lines better, on average, compared to the monofocal group, irrespective of added distance refractive correction. At distance, there were no significant differences in monocular visual acuity between monofocal and ERV IOL groups, with both groups achieving visual acuity results within 0.05 LogMAR of emmetropia.
Multiple regression (GEE) analyses predicting monocular visual acuity adjusted for setting an aspirational micro-monovision target of −0.5D in the non-dominant eye in ERV group. This variable was not associated with any degradation of uncorrected monocular visual acuity at distance (3.00 m) in ERV IOL eyes which targeted micro-monovision (−0.5D) (P = 0.595). The degree of residual astigmatism, however, was found to be statistically significantly associated with uncorrected monocular visual acuity at distance (P < 0.001) and intermediate (P < 0.001 at 1.0 m and P = 0.017 at 0.63 m) and marginally significant at near (P = 0.092). These differences in residual astigmatism were accounted for in the regression analyses.
Analysis of binocular visual acuity revealed statistically significantly better intermediate and near vision in the ERV IOL group compared to the monofocal group, irrespective of whether vision was uncorrected or best distance corrected. Intermediate 0.63 m and near distances were both associated with greater than 1 line of difference on the visual acuity chart which is consistent with the monocular results and suggests that there are similar clinically significant difference in binocular visual acuity between groups at distances less than 1.0 m (Table 4 ). There were no statistically significant differences between groups in visual acuity at distance, with both groups achieving visual acuity within 0.05 LogMAR units of emmetropia.
The degree of residual astigmatism was statistically significantly associated with uncorrected binocular visual acuity at distance (P = < 0.001), intermediate 1.0 m (P = 0.006) and at near (P = 0.023) and marginally insignificant at intermediate 0.63 m (P = 0.053). These differences in visual acuity that were related to residual astigmatism was accounted for in the regression analyses.
Testing of near visual acuity using the British 'N' reading chart revealed clinically and statistically significantly better (P < 0.001) near visual acuity (lower 'N' scores) in the ERV IOL group compared to the monofocal group (Fig. 1) . No individuals in the ERV IOL group had near vision worse than N8 whereas 64.4% of the monofocal group had near vision worse than N8.
Spectacle usage at distance did not differ between groups (Table 5 ). However, there was a significant difference in spectacle usage for near vision with almost three times (93.3%) the use of spectacles in the monofocal group compared with the ERV group (32.6%). The median percentage of time spectacles were used for near vision was 100% (IQR 40%, 100%) for monofocal and 0% (IQR 0%, 20%) for ERVIOL participants.
DISCUSSION
This study compared the ERV IOL, prescribed to achieve micro-monovision, to a standard monofocal IOL, prescribed to achieve emmetropia. While both groups achieved functional distance vision, visual acuity with the ERV IOL was statistically and clinically significantly better than with the monofocal IOL at intermediate and near distances. Participants in the ERV IOL group could read small print with fluent optotype recognition, unaided. This provided them with functional near reading vision without spectacles. The use of spectacles for near vision amongst participants with ERV IOLs was statistically significantly less than for participants with monofocal IOLs. This increased near vision capacity for ERV IOLs recipients resulting in a clinically significant increase in spectacle independence.
The spectacle independence findings are consistent with the results of other studies. 6, 7 The pilot study published by Tecnis, and Pedrotti et al.'s prospective cohort study both used questionnaires to determine spectacle independence. Similar to our study, the ERV IOLs in these studies provided participants with significantly lower dependence on correction of vision with spectacles, while maintaining the same level of visual acuity. 6, 7 It was important to determine whether the manipulation of light by the ERV IOL to provide spectacle independence had any effect on the acuity of distance vision. Consistent with both previous studies 6, 7 our results show that the ERV IOL results in functional distance vision. Further, our analysis of monocular vision demonstrated no significant degradation in distance vision in eyes aspirationally targeting slight myopia compared to eyes targeting emmetropia. These results together indicate that distance visual acuity in ERV IOL recipients is not lost to provide the near and intermediate foci.
This study included a functional reading test (the British 'N' score) comparing ERV IOLs with monofocal IOLs to provide additional information about attainment of near vision with the ERV IOL. This is important as individuals seeking spectacle independence want information on their expected functional capacity within the near range and this study provides new empirical evidence that can help inform expected visual outcomes for recipients of ERV IOLs. This study also assessed binocular visual acuity, which is an important outcome to include because of binocular summation and because it better equates to the circumstances in which a person usually functions. 12, 13 This study's use of micro-monovision for ERV IOLs recipients makes binocular testing even more relevant for comparing visual acuity outcomes between ERV IOL and monofocal IOL groups.
Importantly, this is the first study comparing visual acuity in ERV IOLs and monofocal IOLs to adjust for any effects on visual acuity related to differences in age, treatment for posterior capsular opacification, aspirational targeting of micromonovision, residual astigmatism and correlation between participant's left and right eyes. These analytical features strengthen the confidence that can be had in the study's results.
This study is not without its limitations. The retrospective observational cohort study design by definition, is subject to selection and information bias. Differences in the outcome measures used to assess near visual acuity and spectacle independence in our study from those used in previously published studies of the ERV IOL limit the comparability of the findings. The spectacle independence measures within this study were self-reported and were at risk of recall bias, particularly the questions relating to the percentage of time they used their spectacles. Limitations for assessing reading speed may also be associated with English language and reading proficiency of the patient -which were not assessedrather than visual acuity at near distance. Despite the limitations of our spectacle independence data, we believe that our measure has the advantage of being easy for clinicians and patients to understand while the findings add new and useful information that is not otherwise available in the literature.
Further, the monocular analyses excluded two patients from the ERV IOL group due to missing data for eye dominance. However, sensitivity analyses which imputed the four possible combinations of eye dominance for these patients did not change the results. Additionally, participants in this study had their IOLs set to achieve micro-monovision (ERV group) or emmetropia (monofocal group). Micromonovision is a technique which is used to improve near vision by making one eye slightly myopic and may have also improved the near vision outcomes for the monofocal group if it had been used.
These limitations notwithstanding, this study demonstrates that ERV IOLs, when targeted at micro-monovision, provide significantly better intermediate and near visual acuity than monofocal IOLs set at emmetropia, equivalent distance visual acuity and much higher likelihood of spectacle independence. These findings are important as they provide quantitative information on ERV IOL function in comparison to the gold standard monofocal IOL that can help inform patient decisions about which IOL to choose and what visual outcomes they can expect.
